Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!

Basic Formulation Characterization by In Vitro Precipitation Studies (CAT#: STEM-B-0432-CJ)

Introduction

A biopharmaceutical formulation is a high-end product. It is tailored towards the specific drug substance, its specific characteristics and degradation profiles, and contains stabilizing excipients of various kinds. Knowing the characteristics of a biopharmaceutical formulation is not only relevant during the formulation exercise itself, but also when manufacturing aspects come into play.

Since drug molecules usually have different solid forms, including salts, polycrystals, eutectic, amorphous, hydrates and solvent compounds; moreover, different crystal forms of the same drug molecule may have significant differences in properties such as crystal structure, stability, producibility and bioavailability, which directly affect the efficacy and exploitability of the drug. If the best crystalline form is not well evaluated and selected for development, crystalline changes may occur in the late clinical stage, resulting in significant financial losses due to delayed marketing, and even more significant losses if the drug is withdrawn from the market due to crystalline changes after marketing.




Principle

Molecular size, degree of ionisation, dissolution, precipitation, gastrointestinal (GI) transit times, luminal viscosity, pH, bile salt and phospholipid concentrations, cellular permeation and intestinal drug transport and metabolism are some examples of the factors which can affect absorption of a drug and, therefore, its bioavailability. Possible supersaturation or precipitation are important parameters to consider, as they can significantly affect the bioavailability of an active pharmaceutical ingredient (API). Assessment of potential supersaturation and precipitation is critical, especially in cases where the API is a weak base with low aqueous solubility or a bio-enabling formulation is implemented.

Applications

Biopharmaceutica

Procedure

1. Preparation of samples
2. Transfer the sample to the kit and add the appropriate dissolution medium.
3. Analyse the drug indicator using a suitable method.

Materials

• Sample: Tablet, Capsule, Ointment & More
• Equipment: Miniaturised intrinsic dissolution screening (MINDISS), USP II dissolution apparatus
Advertisement